Debt-to-equity of Aptose Biosciences Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aptose Biosciences Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Aptose Biosciences Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -165%, a 62% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Aptose Biosciences Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -165% +274% +62% 30 Sep 2025
Q2 2025 -196% -2128% -110% 30 Jun 2025
Q1 2025 -270% -559% -193% 31 Mar 2025
Q4 2024 -385% -509% -412% 31 Dec 2024
Q3 2024 -439% -500% -813% 30 Sep 2024
Q2 2024 1931% +1891% +4737% 30 Jun 2024
Q1 2024 290% +262% +941% 31 Mar 2024
Q4 2023 123% +104% +531% 31 Dec 2023
Q3 2023 62% +47% +323% 30 Sep 2023
Q2 2023 40% +28% +239% 30 Jun 2023
Q1 2023 28% +18% +182% 31 Mar 2023
Q4 2022 20% +11% +137% 31 Dec 2022
Q3 2022 15% +7% +103% 30 Sep 2022
Q2 2022 12% +6% +97% 30 Jun 2022
Q1 2022 10% +4% +70% 31 Mar 2022
Q4 2021 8% +2% +38% 31 Dec 2021
Q3 2021 7% +1% +16% 30 Sep 2021
Q2 2021 6% -2% -25% 30 Jun 2021
Q1 2021 6% -3% -34% 31 Mar 2021
Q4 2020 6% -6% -50% 31 Dec 2020
Q3 2020 6% -12% -66% 30 Sep 2020
Q2 2020 8% 30 Jun 2020
Q1 2020 9% 31 Mar 2020
Q4 2019 12% 31 Dec 2019
Q3 2019 18% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.